Filing Details
- Accession Number:
- 0001209191-21-059512
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-10-05 16:53:11
- Reporting Period:
- 2021-10-01
- Accepted Time:
- 2021-10-05 16:53:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1662579 | C4 Therapeutics Inc. | CCCC | Biological Products, (No Disgnostic Substances) (2836) | 475617627 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1825445 | Adam Crystal | C/O C4 Therapeutics, Inc. 490 Arsenal Way #200 Watertown MA 02472 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-10-01 | 15,000 | $4.98 | 15,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-10-01 | 1,712 | $44.25 | 13,288 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-10-01 | 8,176 | $45.32 | 5,112 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-10-01 | 5,112 | $45.99 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-10-01 | 15,000 | $0.00 | 15,000 | $4.98 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 168,108 | 2030-07-02 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on January 21, 2021.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $43.57 to $44.56. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $44.85 to $45.845. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.89 to $46.30. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- This option shall vest and become exercisable in 20 equal quarterly installments, with the first installment vesting on September 5, 2020.
Billionaire Hedge Funds
